Kasios

Bone Therapeutics, Kasios collaborate on optimization of spinal fusion procedures

Monday, November 17, 2014

Bone Therapeutics, a Belgium regenerative therapy company addressing unmet medical needs releated to bone diseases and orthopaedics, and Kasios, a French synthetic bone substitute specialist, have announce a two-year collaboration to develop a novel product for spinal fusion procedures. The collaboration combines Bone Therapeutics’ allogeneic osteoblastic cell therapy product ALLOB with Kasios’s synthetic micro-granules bone substitute. The project is subsidized by the government of the Walloon Region.

[Read More]